Stocktoria
RELMADA THERAPEUTICS, INC. RLMD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-03-03
RELMADA THERAPEUTICS, INC. statistics & valuation
Market cap$701.7M
P / B8.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -61.0% | -174.6% | -101.3% | -102.7% | -56.3% |
| Return on equity | -66.3% | -225.2% | -115.7% | -111.8% | -60.4% |
| Current ratio | 14.62 | 4.45 | 8.00 | 12.26 | 14.83 |
Source: SEC EDGAR filings · CIK 0001553643 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.